As reported by Health News, quoted from Middle East News Agency, American Researchers stated: “Eating only apple every day shall help decrease of risk of atherosclerosis. Robert Disilvestro, the main producer of researches from Ohayo University in America stated: “The said researches have revealed that eating one apple every day for four consecutive weeks, decreases 40% average of a specific matter in blood, which is associated with atherosclerosis”.
The said researches have indicated that apples decrease average of LDL which causes atherosclerosis. Disilvestro emphasized the effectiveness of eating apples and stated: “Antioxidant that exists in apples is more useful for decrease of average of LDL, compared to respective antioxidants existing in other beverages and foodstuffs such as green tea and tomato extract. Apples are enriched with strong antioxidants including Flavonoid and polyphenol. According to results obtained from studies, the effect of antioxidant of 100 grams of apples equals to absorption of 1500 mg of Vitamin C. Antioxidants campaign against influenza. Apples enjoy huge quantities of vitamins and minerals, which are useful for blood strengthening.
Moreover, apples enjoy malic acid and Tartaric Acid, which prevent digestive and liver complications. Apple vinegar, which is used as a beverage, prevents renal calculi. Apple vinegar relieves joint paints. Apple husk contains pectin. Generating galacturonic, pectin may discharge poisonous matters from body. Eating apples may also be useful for obesity, headache, arthritis, bladder inflammation, anemia, tuberculosis, neural inflammation, insomnia, cold, gallbladder calculi, parasites, bad breath and pyorrhea.
Because of anti-immunity property and prevention of cellular multiplication, researchers consider various clinical advantages for astatines in the patients, suffering from cancer. It can easily be said that astatine decreases danger of cancer occurrence. It should be further added that such effect of Astatine, which has been described above, has not been confirmed by scientific societies yet.
According to a past clinical study, which has been contracted in America, researchers compared extent of danger for development of cancer among consumers of Astatine to individuals, who have not received the said medicine.
Occurrence of lung and colon cancers has noticeably decreased among the recipients of Astatine.
Pervious meta-analyses had also evaluated danger of occurrence of various kinds of cancer. Presently, a huge quantity of budget has been allocated to the said field of study.
The most quantity of collected information is associated with consumption of Astatine and breast, lung and colon cancers.
Although a noticeable number of studies of several centers have revealed that there is no relation between receiving Astatine and decrease of occurrence of breast cancer. The persons, who receive fluvastatin, develop breast cancer less than those who don’t receive the said medicine. According to a widespread study in America, it has been propounded that receiving Astatines for a period over six months leads to decrease of cancer prevalence by 55%.
Although over 20 case studies have been done so far in order to evaluate the effect of Astatines in decrease of cancer occurrence, the effectiveness of the said medicine has not been proven yet.
Dr. John Swartzberg is an internist and specialist in infectious disease and chairman of the editorial board of the UC Berkeley Wellness Letter and berkeleywellness.com. He is also a clinical professor emeritus of medicine at the University of California, Berkeley School of Public Health and the University of California, San Francisco School of Medicine. He contributed this article to Live Science's Expert Voices: Op-Ed & Insights.
It's been nearly a century since researchers at the University of California, Berkeley discovered vitamin E, and since then, many studies have looked at the potential health benefits of this antioxidant. After all, in lab experiments, antioxidants neutralize potentially harmful free radicals. Shouldn't they confer the same benefits in the body? Over the years, supplement makers and some researchers predicted that vitamin E would help prevent cancer, heart disease and Alzheimer's disease, as well as help maintain eyesight and keep skin glowing. Fueled by hope and hype, vitamin E supplement sales soared.
But what does the research actually show? Early studies that found a benefit, mostly for heart disease, were observational and not always well designed: Researchers asked people if they took vitamin E supplements and then looked at their health.
More recent studies, however — most of them well-designed clinical trials — have found no benefit. In fact, a few studies suggest that high doses of vitamin E might actually be harmful. [Dangers Lurking in Supplements Prove Need for Oversight (Op-Ed)]
Here are some findings from the more important studies on vitamin E supplements:
Heart Disease and Stroke: In 2008, the Physicians' Health Study II looked at more than 14,000 male doctors taking high doses of vitamin C or vitamin E for eight years. Neither supplement reduced heart attacks, strokes or cardiovascular deaths. In fact, vitamin E slightly increased the risk of hemorrhagic (bleeding) strokes. This study was followed by an analysis of many studies in 2010 that found vitamin E supplements increase the risk of hemorrhagic strokes by 22 percent.
Longevity: According to a review of studies that included almost half a million people, antioxidant supplements (including vitamin E, beta carotene, vitamin C and selenium) did not prolong life or protect against disease. This review was done by the Cochrane Collaboration, an independent group that evaluates health research evidence. Other large reviews also have suggested that vitamin E supplements and other antioxidant pills are associated with increased mortality.
Vitamin supplements, including vitamin E, have not proved protective, according to a 2007 study funded by the National Cancer Institute (NCI). Smokers who took E supplements actually had a slightly higher risk of lung cancer. Though this is not the final word, the researchers warned smokers that the supplements "may be detrimental."
Prostate Cancer: A 2011 study funded by the National Cancer Institute examined whether vitamin E might help prevent prostate cancer. Earlier research had found no benefit or harm from vitamin E. This large study of 35,533 men over a period of three years came up with a surprising result. Healthy men taking vitamin E actually had a higher incidence of prostate cancer than other men.
In general, there's little clinical research showing that vitamin E supplements benefit your health. Most recent clinical trials have been negative or inconclusive.
expert voices, op-ed
There are, however, people with a couple of conditions who may want to discuss these supplements with their doctor. Research has found that vitamin E supplements there is some evidence that vitamin E may reduce liver damage caused by inflammation from aggressive nonalcoholic fatty liver disease (NAFLD), a disease associated with obesity. There's no standard medical treatment for this life-threatening disease. Vitamin E therapy showed an improvement in patients with aggressive symptoms who do not have diabetes or cirrhosis.
People with macular degeneration, the leading cause of blindness in adults, should also talk with their doctor about special formulations of antioxidant supplements — including vitamin E — that slow progression of this incurable eye disease. Two large clinical trials sponsored by the National Eye Institute found that formulations of vitamin C, vitamin E, beta carotene, lutein, and zeaxanthin reduced the risk this serious disease progressing by 25 percent.
My advice? For most people, healthy food is the best bet. No studies have found harm from consuming the low levels of vitamin E found naturally in foods such as nuts, seeds, vegetable oils, whole grains and leafy greens.
If you're diagnosed with NAFLD, ask your doctor whether the potential benefit from vitamin E might outweigh risks in your case. If you're at high risk for developing macular degeneration, ask your eye care doctor if you should consider taking the special formulation of antioxidants and zinc.
Follow all of the Expert Voices issues and debates — and become part of the discussion — on Facebook, Twitter and Google+. The views expressed are those of the author and do not necessarily reflect the views of the publisher. This version of the article was originally published on Live Science.
According to studies about the effect of astatines on infectious diseases, most of studies have focused on such diseases as sepsis, pneumonia, and influenza. Relying on a widespread study, it has recently revealed the advantages of receiving Astatines by the patients suffering of sepsis. A clinical trial of several centers in Japan has shown noticeable decrease of death caused by Influenza and pneumonia among consumers of an average dosage of Astatine.
Various studies have been contracted on role of Astatine in prevention and treatment of Alzheimer’s disease. Simultaneous with decrease of Cholesterol due to consuming Astatines by the patients suffering from Alzheimer ’s disease, receiving Atorvastatin, patients’ wisdom showed improvement of symptoms of the said disease and memory capability after six months of consumption. The effect of the said disease has fixed for one year after consumption. Past studies have also revealed that astatines enjoy protective effect against Alzheimer ’s disease.
Concerning the fact that Astatines enjoy anti-inflammatory effects, using the said medicine for the patients, suffering from chronic occlusive pulmonary disorders and other pulmonary complications, associated with inflammatory degeneration, has been studied.
According to a study, contracted earlier, the effect of Astatine on function of lungs of smokers was examined and respective results of the said study revealed that receiving the said group of medicines shall decrease emergency respiratory visitations, compared to other groups of medicines.
Considering another study, Astatines have protective effect on function of lungs of old people (discarding record of smoking by the said group). Moreover, considering the smokers, who gave up smoking after a long period or those who had recently started smoking and now, they gave up this habit, Astatine was prescribed for the aforesaid groups. Compared to the patients, who don’t receive Astatine, FEVI and FVC have decreased by 50% at least.
According to a recent study, contracted in Japan, Astatines slow down aggravation of chronic occlusive pulmonary diseases and enjoys noticeable advantages in decrease of mortality due to the said complications.